European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS
Key facts
- Who runs it
- University Hospital, Grenoble
- Where
- France, Germany, Sweden, and Switzerland8 sites in 4 countriesChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 60 people, planned
- Started
- Sept 2016
- Expected to end
- Apr 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Deep Brain Stimulation
- Record updated
- 29 November 2023
Who can take part
- Age
- 18 years to 69 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- OCD for > 5 years
- YBOCS> 25 and/or YBOCS sub-scale >15
- GAF< 45
- 3 or more documented SRI trials, including clomipramine (10-12 weeks at adequate dose)
- SRI augmentation for > 4 weeks with at least one antipsychotic and with one of the following: lithium, clonazepam
- Adequate trial of CBT (Exposure Therapy and Response Prevention) (intolerance or >15 sessions)
- Ability to provide informed consent
Who cannot take part
- Substance abuse or dependence within the previous six months
- Brain pathology, such as moderate or marked cerebral atrophy, stroke, tumor or previous neurosurgical procedures (i.e. capsulotomy etc), history of cognitive impairment and cognitive deterioration (Addenbrooke's Cognitive Examination ACE score of < 80)
- Contra-indications to surgery, anaesthesia, or MRI
- Lifetime diagnosis of psychosis or bipolar disorder
- Current DSM-5 personality disorder of Cluster A (e.g., paranoid or schizotypal personality disorder) or B (e.g., borderline or antisocial personality disorder)
- Hoarding (if the only OCD symptom)
- OCD with poor insight (BABS score > 12)
- Baseline Montgomery and Asberg (MADRS) suicidality item (item 10) score >2
- compulsory hospitalization/ care; pregnant or nursing patients
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 69 years old?
This trial has no sites in United States.
It has sites in 4 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Obsessive-Compulsive Disorder (OCD) is among the most disabling psychiatric disorders as more than 40% of patients are resistant to the standard pharmacological and psychotherapy approaches and about 10% show severe disability and require institutionalization. These resistant patients may benefit from new surgical therapeutic approaches such as Deep Brain Stimulation (DBS) using high frequency stimulation of specific cerebral regions to modulate neural networks. Although promising, these results need nevertheless to be replicated and confirmed within a larger cohort of patients and considering a different main objective, instead of clinical improvement only. Indeed, despite a positive treatment response, adaptive functioning and quality of life may continue to be negatively impacted in OCD. Thus beyond symptom reduction, health-related quality of life (QoL) represents a more important objective of a treatment, as it includes both the individual's functional status and the individual's subjective perception of the impact of the illness on the patient's life. STN DBS induces significant clinical improvement, which may not be proportional to the QoL gain. Consequently, QoL appears to be a better outcome to target in the coming studies than clinical improvement alone. THe investigators thus propose a prospective study assessing the QoL changes of resistant OCD patients under STN DBS+BMT versus Best Medical Treatment (BMT) at 12 months, in order to assess the DBS induced gain in QoL in BMT-managed patients versus BMT alone.
The 2 groups in the trial
- Deep Brain StimulationExisting treatment, for comparison
DBS surgical procedure scheduled and realized
- Control groupNo study treatment, for comparison
medical treatment (psycho- and pharmaco-therapy) will continue to be given and optimized according to the defined BMT strategies and criteria
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS Versus Best Medical Treatment
- Fit questions
- Built from NCT02844049, who can take part
- Record updated
- 29 November 2023